B

Balaxi Pharmaceuticals Ltd
NSE:BALAXI

Watchlist Manager
Balaxi Pharmaceuticals Ltd
NSE:BALAXI
Watchlist
Price: 25.84 INR 0.08% Market Closed
Market Cap: 285.3m INR

Intrinsic Value

The intrinsic value of one BALAXI stock under the Base Case scenario is 308 INR. Compared to the current market price of 25.84 INR, Balaxi Pharmaceuticals Ltd is Undervalued by 92%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BALAXI Intrinsic Value
308 INR
Undervaluation 92%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case
Compare BALAXI to

Fundamental Analysis

Balaxi Pharmaceuticals Ltd
Company Overview
Loading...
Economic Moat
Loading...
Contacts
Loading...
How do you feel about BALAXI?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Balaxi Pharmaceuticals Ltd

Current Assets 2.4B
Cash & Short-Term Investments 394m
Receivables 1.1B
Other Current Assets 895m
Non-Current Assets 675m
PP&E 363m
Intangibles 267m
Other Non-Current Assets 45m
Current Liabilities 545m
Accounts Payable 76m
Short-Term Debt 304m
Other Current Liabilities 165m
Non-Current Liabilities 241m
Long-Term Debt 230m
Other Non-Current Liabilities 11m
Efficiency

Free Cash Flow Analysis
Balaxi Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Balaxi Pharmaceuticals Ltd

Revenue
3B INR
Cost of Revenue
-1.7B INR
Gross Profit
1.3B INR
Operating Expenses
-1B INR
Operating Income
294m INR
Other Expenses
-105.1m INR
Net Income
188.9m INR
Fundamental Scores

BALAXI Profitability Score
Profitability Due Diligence

Balaxi Pharmaceuticals Ltd's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROE
Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
43/100
Profitability
Score

Balaxi Pharmaceuticals Ltd's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

BALAXI Solvency Score
Solvency Due Diligence

Balaxi Pharmaceuticals Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
High Altman Z-Score
73/100
Solvency
Score

Balaxi Pharmaceuticals Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BALAXI Price Targets Summary
Balaxi Pharmaceuticals Ltd

There are no price targets for BALAXI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BALAXI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y